Functional Magnetic Resonance Imaging of the Brain (FMRIB) Centre, University of Oxford, Department of Clinical Neurology, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, United Kingdom.
Neuroimage. 2012 Jan 2;59(1):565-72. doi: 10.1016/j.neuroimage.2011.07.059. Epub 2011 Aug 7.
There is a well-established association between APOE genotype and the risk of developing Alzheimer's disease (AD). Relative to individuals with the common ε3/ε3 genotype, carriers of the ε4 allele are at increased risk of developing AD, while carriers of the ε2 allele appear to be protected against the disease. However, we recently reported that in a sample of cognitively healthy adults, both ε4 and ε2 carriers showed nearly identical changes in the pattern of fMRI activity during memory and non-memory tasks, relative to ε3 homozygotes. These findings suggest that the effects of APOE on brain function are not tightly linked to the effects of this gene on AD risk. Here we test the hypothesis that APOE has an intrinsic effect on the brain's functional networks. Resting-state fMRI was used to compare the pattern of functional connectivity of a variety of resting-state networks between 77 cognitively healthy participants aged 32 to 55 with different APOE genotypes (23 ε2/ε3, 20 ε3/ε3, 26 ε3/ε4, and 8 ε4/ε4). Differences between genotype groups were found in two hippocampal networks, the auditory network, the left frontal-parietal network, and the lateral visual network. While there was considerable variety in the brain regions affected and the direction of change across networks, the main finding was that changes in functional connectivity were similar in ε4 and ε2 carriers, relative to ε3 homozygotes. APOE appears to have an intrinsic effect on the differentiation of functional networks in the brain. This effect is apparent in cognitively healthy adults and does not manifest in a manner reflective of the link between APOE and AD risk. Rather, the effects of APOE on brain function may relate to the role of this gene in neurodevelopment.
载脂蛋白 E 基因型与阿尔茨海默病(AD)的发病风险之间存在明确的关联。与常见的 ε3/ε3 基因型个体相比,ε4 等位基因携带者患 AD 的风险增加,而 ε2 等位基因携带者似乎对该疾病具有保护作用。然而,我们最近报告称,在认知健康的成年人样本中,与 ε3 纯合子相比,ε4 和 ε2 携带者在记忆和非记忆任务期间 fMRI 活动模式中都表现出几乎相同的变化。这些发现表明,APOE 对大脑功能的影响与该基因对 AD 风险的影响并不紧密相关。在这里,我们检验了 APOE 对大脑功能网络具有内在影响的假设。使用静息态 fMRI 比较了 77 名年龄在 32 至 55 岁之间、具有不同 APOE 基因型(23 名 ε2/ε3、20 名 ε3/ε3、26 名 ε3/ε4 和 8 名 ε4/ε4)的认知健康参与者之间各种静息态网络的功能连接模式。在两个海马网络、听觉网络、左侧额顶叶网络和外侧视觉网络中发现了基因型组之间的差异。虽然跨网络的受影响脑区和变化方向存在很大差异,但主要发现是与 ε3 纯合子相比,ε4 和 ε2 携带者的功能连接变化相似。APOE 似乎对大脑功能网络的分化具有内在影响。这种影响在认知健康的成年人中很明显,并且不以反映 APOE 与 AD 风险之间联系的方式表现出来。相反,APOE 对大脑功能的影响可能与该基因在神经发育中的作用有关。